Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Oncology Institute, Inc. (DFPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Investor presentation
Docs: "1THE ONCOLOGY INSTITUTE OF HOPE"
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "The Oncology Institute Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance"
07/10/2023 SC 13G/A FMR LLC reports a 6.3% stake in ONCOLOGY INSTITUTE INC/THE
06/12/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "1/2 The Oncology Institute Announces Leadership Transition Dr. Daniel Virnich"
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "The Oncology Institute Reports First Quarter 2023 Financial Results and Reaffirms Full Year 2023 Guidance"
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/03/2023 SC 13G/A Agajanian Richy reports a 4.8% stake in Oncology Institute, Inc.
03/27/2023 8-K Quarterly results
03/16/2023 10-K Annual Report for the period ended December 31, 2022
03/09/2023 8-K Quarterly results
Docs: "The Oncology Institute Reports Fourth Quarter and Full Year 2022 Financial Results and Guidance for 2023"
02/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
02/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
02/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
02/09/2023 SC 13G/A FMR LLC reports a 16.6% stake in ONCOLOGY INSTITUTE INC/THE
01/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/09/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
01/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
12/30/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/01/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
12/01/2022 8-K Quarterly results
11/14/2022 8-K Investor presentation
Docs: "Investor Presentation November 2022 Disclaimer Forward Looking Statements Financial"
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
Docs: "The Oncology Institute Reports Third Quarter 2022 Financial Results and Updates Full Year 2022 Guidance"
11/07/2022 SC 13D/A Havencrest Healthcare Partners, L.P. reports a 18.9% stake in The Oncology Institute, Inc.
09/27/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy